Literature DB >> 18981134

TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Haishan Li1, Kun Luo, C David Pauza.   

Abstract

Vgamma2 Vdelta2 T cells in human peripheral blood recognize phosphoantigen and play important roles in host defense and immunoregulation. The TCR is required for Vgamma2 Vdelta2 T cell responses to phosphoantigen, but less is known about soluble or cell-associated costimulatory molecules. In this study, we show that human Vgamma2 Vdelta2 T cell responses to phosphoantigen, including activation, proliferation, cytokine production, and tumor cell cytotoxicity, require TNF-alpha binding to its receptor, with a preference for TNFR2. Because stimulated Vgamma2 Vdelta2 cells also produce TNF-alpha, this may be a positive control mechanism to sustain the response. Impaired proliferation in the presence of TNF-alpha or TNFR blocking agents was partially rescued by a TLR2 agonist, Pam(3)Cys. Our studies demonstrate that TNF-alpha plays a critical role in regulating human Vgamma2 Vdelta2 T cell immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981134      PMCID: PMC3753041          DOI: 10.4049/jimmunol.181.10.7131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling.

Authors:  J i Inoue; T Ishida; N Tsukamoto; N Kobayashi; A Naito; S Azuma; T Yamamoto
Journal:  Exp Cell Res       Date:  2000-01-10       Impact factor: 3.905

2.  Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.

Authors:  Andrew M Hebbeler; Cristiana Cairo; Jean Saville Cummings; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2006-11-28       Impact factor: 6.968

3.  Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.

Authors:  Alan A Z Alexander; Amudhan Maniar; Jean-Saville Cummings; Andrew M Hebbeler; Dan H Schulze; Brian R Gastman; C David Pauza; Scott E Strome; Andrei I Chapoval
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

4.  Tumor necrosis factor-alpha at the intersection of mycobacterial immunity and pathogenesis: an important new address in medicine.

Authors:  Michael D Iseman; Aryeh Fischer
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

5.  V gamma 9V delta 2 T cells in human legionellosis.

Authors:  M Kroca; A Johansson; A Sjöstedt; A Tärnvik
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

6.  In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors.

Authors:  P S Evans; P J Enders; C Yin; T J Ruckwardt; M Malkovsky; C D Pauza
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

7.  Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes.

Authors:  F Dieli; M Troye-Blomberg; J Ivanyi; J J Fournié; A M Krensky; M Bonneville; M A Peyrat; N Caccamo; G Sireci; A Salerno
Journal:  J Infect Dis       Date:  2001-09-28       Impact factor: 5.226

8.  CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis.

Authors:  S Thoma-Uszynski; S Stenger; R L Modlin
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

9.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network.

Authors:  Kevin L Winthrop; S Yamashita; S E Beekmann; P M Polgreen
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

View more
  22 in total

Review 1.  Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.

Authors:  Hamid Reza Mirzaei; Hamed Mirzaei; Sang Yun Lee; Jamshid Hadjati; Brian G Till
Journal:  Cancer Lett       Date:  2016-07-05       Impact factor: 8.679

Review 2.  Modulation of γδ T cell responses by TLR ligands.

Authors:  Daniela Wesch; Christian Peters; Hans-Heinrich Oberg; Kathrin Pietschmann; Dieter Kabelitz
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

3.  Interplay of T-cell receptor and interleukin-2 signalling in Vγ2Vδ2 T-cell cytotoxicity.

Authors:  Haishan Li; C David Pauza
Journal:  Immunology       Date:  2010-08-25       Impact factor: 7.397

Review 4.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

5.  Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.

Authors:  Haishan Li; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2010-11-25       Impact factor: 6.968

Review 6.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

7.  Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection.

Authors:  Martin S Davey; Chan-Yu Lin; Gareth W Roberts; Sinéad Heuston; Amanda C Brown; James A Chess; Mark A Toleman; Cormac G M Gahan; Colin Hill; Tanya Parish; John D Williams; Simon J Davies; David W Johnson; Nicholas Topley; Bernhard Moser; Matthias Eberl
Journal:  PLoS Pathog       Date:  2011-05-12       Impact factor: 6.823

8.  Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells.

Authors:  Haishan Li; C David Pauza
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

Review 9.  Roles of γδ T cells in the pathogenesis of autoimmune diseases.

Authors:  Dinglei Su; Minning Shen; Xia Li; Lingyun Sun
Journal:  Clin Dev Immunol       Date:  2013-02-28

10.  Granzyme A produced by γ(9)δ(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen.

Authors:  Charles T Spencer; Getahun Abate; Isaac G Sakala; Mei Xia; Steven M Truscott; Christopher S Eickhoff; Rebecca Linn; Azra Blazevic; Sunil S Metkar; Guangyong Peng; Christopher J Froelich; Daniel F Hoft
Journal:  PLoS Pathog       Date:  2013-01-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.